RSS

carbamazepine

Data, recently published in the journal Epilepsia, has demonstrated once-daily monotherapy, Zebinix (esclicarbazeptine acetate), is non-inferior to twice-daily controlled released carbamazepine in the treatment of newly diagnosed focal epilepsy more

News